-
-
-
-
-
-
-
MiNK Therapeutics' (INKT) AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress
-
-
-
-
-
-
-
MiNK Therapeutics (INKT) Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in Solid Tumors
-
-
-
-
-
-
-
MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting
-
-
-
-
-
-
-
MiNK Therapeutics Announces Patients Dosed with AgenT-797 iNKT Cell Therapy in Solid Tumor Cancers
-
-
51,661 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All